[Monoclonal antibodies in diseases of viral origin].
D000820:Animal Diseases / Q000276:immunology / Q000517:prevention & control; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology* / Q000627:therapeutic use; D000914:Antibodies, Viral / Q000276:immunology* / Q000627:therapeutic use; D000918:Antibody Specificity; D000956:Antigens, Viral / Q000276:immunology / Q000302:isolation & purification; D000970:Antineoplastic Agents / Q000008:administration & dosage; D000998:Antiviral Agents / Q000008:administration & dosage; D014644:Genetic Variation; D006566:Herpesviridae Infections / Q000276:immunology / Q000628:therapy; D006801:Humans; D006824:Hybridization, Genetic; D007167:Immunotherapy; D051379:Mice; D009369:Neoplasms / Q000276:immunology / Q000628:therapy; D011818:Rabies / Q000517:prevention & control; D011820:Rabies virus / Q000276:immunology; D012703:Serotyping / Q000379:methods; D012756:Sheep; D014777:Virus Diseases / Q000175:diagnosis / Q000276:immunology* / Q000628:therapy; D014780:Viruses / Q000145:classification / Q000235:genetics / Q000276:immunology
D000911:Antibodies, Monoclonal; D000914:Antibodies, Viral; D000956:Antigens, Viral; D000970:Antineoplastic Agents; D000998:Antiviral Agents
Anticuerpos monoclonales en enfermedades de origen viral.